Estimated read time: 2-3 minutes
Sept 21 — Oura kicked off the roadshow for its US initial public offering on Monday, targeting a fully-diluted valuation โof $15.62 billion as the smart ring maker tests investor appetite for consumer technology companies after a tepid start to the fall IPO season.
The IPO, expected sometime next week, comes as markets โhave been on edge in recent weeks over uncertainty around the AI trade, rising bond yields and a shifting Federal Reserve rate outlook.
Oura โ and some of its existing investors plan to โraise as much as $2.2 billion through the sale โ of 50 million shares at the top of the indicated price range of $40 to $44.
"Oura is the first โreal test of US appetite โafter a sluggish September so far and a period of more volatile markets. If it โ comes strongly out the gate, it will encourage other issuers," โ said Samuel Kerr, global head of equity capital markets at Mergermarket.
"However, a weaker IPO might set alarm bells ringing that market sentiment may be turning."
Weight-loss drugmaker Eli Lilly has indicated interest in purchasing up to $100 million of the shares, while investment firm Dragoneer has indicated interest in buying up to $300 million worth of shares.
PRICES IN DEMAND FOR HIGH-TECH HEALTH MONITORS
Smart rings are carving out a โniche between traditional fitness trackers and smartwatches, capitalizing on demand for personalized โwellness insights while offering a smaller, screen-free way to monitor health round the clock with a longer battery life.
Oura has helped popularize the device, which tracks metrics such as heart health, activity and sleep.
The health-tech company sold 3.6 million Oura Rings in the 12 months ended June 30, according to its IPO prospectus. Its revenue for the nine months ended June 30 surged roughly 74% year-over-year to $1.21 billion.
The company expects to end fiscal 2026 with roughly 5.7 million paid members, representing 96% โgrowth over the prior year.
"One of Oura's strengths is that it is beginner friendly, fashionable and feels more like an easy โadd-on to everyday โlife, compared with โ some wearables that are more geared toward serious athletes and performance tracking," Kat Liu, vice president at IPOX, said.
"The valuation is clearly pricing in continued strong growth and a further shift toward higher-margin recurring revenue."
The company, founded over a decade ago in Finland, reached a valuation of about $11 billion in a late-stage funding round โlast year.
Goldman Sachs, Morgan Stanley, โand J.P. Morgan are the lead underwriters of the IPO.
The โcompany is expected to price โ its IPO and begin โtrading on the Nasdaq under the ticker symbol "OURA" next week.
(Reporting by Manya Saini in Bengaluru; Editing by Shinjini Ganguli โand Leroy Leo)





